Grants and Contributions:
Title:
Establishing the production of fresh hepatocytes isolated from chimeric mouse with humanized liver
Agreement Number:
916320
Agreement Value:
$176,000.00
Agreement Date:
Nov 1, 2018 - Mar 31, 2020
Description:
The project goal is to establish the sustainable production of PXB-Cells® (hepatocytes isolated from chimeric mouse with humanized liver) at KMT Hepatech facility in Edmonton. Quality Control procedures and packing process for shipment will be optimized.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T6N 1H1
Reference Number:
172-2018-2019-Q3-916320
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
873407811
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 10,000 dollars. Edmonton Strathcona 48019
Amendment Date
Feb 18, 2020
Recipient's Legal Name:
KMT Hepatech Inc.
Federal Riding Name:
Edmonton Mill Woods
Federal Riding Number:
48017
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
621510
Amendments: